Get startedLog in
    Picture of CARsgen Therapeutics Holdings logo

    2171 — CARsgen Therapeutics Holdings News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMid CapMomentum Trap
    All News

    Brief: CARsgen Announces First Patient Enrollment In The Confirmatory Phase II Clinical Trial Of Ct041 In China

    Picture of CARsgen Therapeutics Holdings logoCARsgen Therapeutics Holdings
    23/03/2022 13:23
    March 23 (Reuters) - CARsgen Therapeutics Holdings Ltd
 2171.HK :
    * CARSGEN ANNOUNCES FIRST PATIENT ENROLLMENT IN THE
CONFIRMATORY
PHASE II CLINICAL TRIAL OF CT041 IN CHINA

Source text for Eikon:  ID:nPn30lClfa 
Further company coverage:  2171.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on CARsgen Therapeutics Holdings

    See all news